Arvinas Appoints Linda Bain to its Board of Directors
June 11, 2020 07:00 ET
|
Arvinas Inc.
NEW HAVEN, Conn., June 11, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Arvinas to Present Virtually at the Goldman Sachs 41st Annual Global Healthcare Conference
June 05, 2020 07:00 ET
|
Arvinas Inc.
NEW HAVEN, Conn., June 05, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive Metastatic Breast Cancer
May 28, 2020 07:30 ET
|
MacroGenics, Inc.
- Advisory committee meeting not required; PDUFA goal date unchanged Rockville, MD, May 28, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical...
Arvinas to Hold Virtual 2020 Annual Meeting of Stockholders
May 20, 2020 16:30 ET
|
Arvinas Inc.
NEW HAVEN, Conn., May 20, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Biotheranostics’ Breast Cancer Index® predicts benefit from two-and-a-half versus five years of extended endocrine therapy in HR+ breast cancer patients treated in the IDEAL trial
May 15, 2020 08:00 ET
|
Biotheranostics, Inc.
San Diego, CA, May 15, 2020 (GLOBE NEWSWIRE) -- Novel evidence demonstrating the ability of Breast Cancer Index to predict preferential endocrine response in distinct subgroups of HR+ early stage...
Multimedia Update: FDA Grants Accelerated Approval for Immunomedics’ Trodelvy in Previously-Treated Metastatic Triple-Negative Breast Cancer
April 23, 2020 08:00 ET
|
Immunomedics, Inc.
First FDA-approved antibody-drug conjugate that targets the Trop-2 antigen Trodelvy is the first antibody-drug conjugate approved by FDA specifically for the treatment of relapsed or refractory...
Biotheranostics Announces Chief Commercial Officer
April 01, 2020 08:00 ET
|
Biotheranostics, Inc.
San Diego, CA, April 01, 2020 (GLOBE NEWSWIRE) -- On April 1, 2020, company veteran and Vice President of Sales, Matt Sargent, was promoted to the position of Chief Commercial Officer. In this...
Todos Medical Announces Publication Demonstrating Potential of FTIR Platform to Identify Bacterial and Viral Infections
March 02, 2020 08:50 ET
|
Todos Medical Ltd.
Todos evaluating applying its proprietary FTIR platform towards the novel coronavirusSeeking appropriate partners to get access to patient samples to train its AI platform REHOVOT, Israel and NEW...
Breast Cancer Conference Brings Young Survivors Together
February 27, 2020 12:53 ET
|
Young Survival Coalition
Los Angeles, CA, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Young Survival Coalition (YSC) brings its fifth annual conference to Los Angeles, California, March 6-8, 2020, where it will host more than 600...
Young Survival Coalition Welcomes New Board Leadership and Members
February 27, 2020 12:45 ET
|
Young Survival Coalition
New York, NY, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Young Survival Coalition (YSC) announces new leadership for its Board of Directors. Desirée A.H. Walker, President, and John Hennessy, Vice President,...